269 related articles for article (PubMed ID: 37301862)
1. Discovery of senolytics using machine learning.
Smer-Barreto V; Quintanilla A; Elliott RJR; Dawson JC; Sun J; Campa VM; Lorente-Macías Á; Unciti-Broceta A; Carragher NO; Acosta JC; Oyarzún DA
Nat Commun; 2023 Jun; 14(1):3445. PubMed ID: 37301862
[TBL] [Abstract][Full Text] [Related]
2. Discovering small-molecule senolytics with deep neural networks.
Wong F; Omori S; Donghia NM; Zheng EJ; Collins JJ
Nat Aging; 2023 Jun; 3(6):734-750. PubMed ID: 37142829
[TBL] [Abstract][Full Text] [Related]
3. Targeting cellular senescence with senotherapeutics: senolytics and senomorphics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
FEBS J; 2023 Mar; 290(5):1362-1383. PubMed ID: 35015337
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in the discovery of senolytics.
Zhang L; Pitcher LE; Prahalad V; Niedernhofer LJ; Robbins PD
Mech Ageing Dev; 2021 Dec; 200():111587. PubMed ID: 34656616
[TBL] [Abstract][Full Text] [Related]
5. Senolytics and the compression of late-life mortality.
Kowald A; Kirkwood TBL
Exp Gerontol; 2021 Nov; 155():111588. PubMed ID: 34637949
[TBL] [Abstract][Full Text] [Related]
6. From the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs.
L'Hôte V; Mann C; Thuret JY
Open Biol; 2022 Sep; 12(9):220171. PubMed ID: 36128715
[TBL] [Abstract][Full Text] [Related]
7. Strategies for senolytic drug discovery.
Power H; Valtchev P; Dehghani F; Schindeler A
Aging Cell; 2023 Oct; 22(10):e13948. PubMed ID: 37548098
[TBL] [Abstract][Full Text] [Related]
8. Cellular senescence and senolytics: the path to the clinic.
Chaib S; Tchkonia T; Kirkland JL
Nat Med; 2022 Aug; 28(8):1556-1568. PubMed ID: 35953721
[TBL] [Abstract][Full Text] [Related]
9. Chemical Strategies for the Detection and Elimination of Senescent Cells.
García-Fleitas J; García-Fernández A; Martí-Centelles V; Sancenón F; Bernardos A; Martínez-Máñez R
Acc Chem Res; 2024 May; 57(9):1238-1253. PubMed ID: 38604701
[TBL] [Abstract][Full Text] [Related]
10. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
[TBL] [Abstract][Full Text] [Related]
11. Obesity, Senescence, and Senolytics.
Chaib S; Tchkonia T; Kirkland JL
Handb Exp Pharmacol; 2022; 274():165-180. PubMed ID: 34697668
[TBL] [Abstract][Full Text] [Related]
12. The costs and benefits of senotherapeutics for human health.
Raffaele M; Vinciguerra M
Lancet Healthy Longev; 2022 Jan; 3(1):e67-e77. PubMed ID: 36098323
[TBL] [Abstract][Full Text] [Related]
13. A guide to senolytic intervention in neurodegenerative disease.
Lee S; Wang EY; Steinberg AB; Walton CC; Chinta SJ; Andersen JK
Mech Ageing Dev; 2021 Dec; 200():111585. PubMed ID: 34627838
[TBL] [Abstract][Full Text] [Related]
14. Promises and challenges of senolytics in skin regeneration, pathology and ageing.
Pils V; Ring N; Valdivieso K; Lämmermann I; Gruber F; Schosserer M; Grillari J; Ogrodnik M
Mech Ageing Dev; 2021 Dec; 200():111588. PubMed ID: 34678388
[TBL] [Abstract][Full Text] [Related]
15. Senolytics and senomorphics: Natural and synthetic therapeutics in the treatment of aging and chronic diseases.
Lagoumtzi SM; Chondrogianni N
Free Radic Biol Med; 2021 Aug; 171():169-190. PubMed ID: 33989756
[TBL] [Abstract][Full Text] [Related]
16. Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans.
Zhu Y; Prata LGPL; Gerdes EOW; Netto JME; Pirtskhalava T; Giorgadze N; Tripathi U; Inman CL; Johnson KO; Xue A; Palmer AK; Chen T; Schaefer K; Justice JN; Nambiar AM; Musi N; Kritchevsky SB; Chen J; Khosla S; Jurk D; Schafer MJ; Tchkonia T; Kirkland JL
EBioMedicine; 2022 Mar; 77():103912. PubMed ID: 35292270
[TBL] [Abstract][Full Text] [Related]
17. Short senolytic or senostatic interventions rescue progression of radiation-induced frailty and premature ageing in mice.
Fielder E; Wan T; Alimohammadiha G; Ishaq A; Low E; Weigand BM; Kelly G; Parker C; Griffin B; Jurk D; Korolchuk VI; von Zglinicki T; Miwa S
Elife; 2022 May; 11():. PubMed ID: 35507395
[TBL] [Abstract][Full Text] [Related]
18. Senotherapeutics for mesenchymal stem cell senescence and rejuvenation.
Wong PF; Dharmani M; Ramasamy TS
Drug Discov Today; 2023 Jan; 28(1):103424. PubMed ID: 36332835
[TBL] [Abstract][Full Text] [Related]
19. Current senolytics: Mode of action, efficacy and limitations, and their future.
Rad AN; Grillari J
Mech Ageing Dev; 2024 Feb; 217():111888. PubMed ID: 38040344
[TBL] [Abstract][Full Text] [Related]
20. Potential Use of Senolytics for Pharmacological Targeting of Precancerous Lesions.
Saleh T; Carpenter VJ
Mol Pharmacol; 2021 Dec; 100(6):580-587. PubMed ID: 34544896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
